Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Of the 34 undifferentiated endometrial carcinomas examined, 17 (50%) exhibited SWI (show SMARCA1 ELISA Kits)/SNF (show SNRPA ELISA Kits) complex inactivation, with 11 tumors showing complete loss of both ARID1A (show ARID1A ELISA Kits) and ARID1B (show ARID1B ELISA Kits), 5 showing complete loss of BRG1 and 1 showing complete loss of INI1 (show SMARCB1 ELISA Kits). Ten of the remaining 17 undifferentiated carcinomas showed the following alterations: 5 tumors (15%) showed loss of ARID1A (show ARID1A ELISA Kits) only with intact ARID1B (show ARID1B ELISA Kits), BRG1, and INI1 (show SMARCB1 ELISA Kits) expression.
Data suggest that the BRG1/STAT3 (show STAT3 ELISA Kits)/VEGFC (show VEGFC ELISA Kits) in tumor-associated lymphangiogenesis might lead to the discovery of novel therapeutic targets in the treatment of cancers with BRG1 loss of function.
Results suggest that targeting the enzymatic activity of BRG1 would be an effective adjuvant therapy for breast cancer.
The vast majority of SCCOHT demonstrate genomic SMARCA4 loss with only rare co-occurring alterations. Data support a role for CGP in the diagnosis and management of SCCOHT and of other lesions with overlapping histological and clinical features, since identifying the former by genomic profile suggests benefit from an appropriate regimen and treatment decisions.
BRG1 can promote VEGF-A (show VEGFA ELISA Kits) expression and angiogenesis in colorectal cancer and BRG1 may be a novel drug target for the treatment of colorectal cancer.
The BRG1/SIRT1 (show SIRT1 ELISA Kits)/p53 (show TP53 ELISA Kits) signal axis is a novel mechanism of cell senescence in CRC (show CALR ELISA Kits).
BRG1 and SMARCAL1 (show SMARCAL1 ELISA Kits), members of the ATP-dependent chromatin remodelling family, are shown to co-regulate the transcription of DROSHA (show DROSHA ELISA Kits), DGCR8 (show DGCR8 ELISA Kits), and DICER (show DICER1 ELISA Kits) in response to double-strand DNA breaks.
BRG1 was significantly increased in hepatocellular carcinoma. Overexpression of BRG1 increases cell growth and invasiveness in HCC (show FAM126A ELISA Kits).
Case Report: SMARCA4 nonsense/frameshift mutations responsible for concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
i-motif structures in long cytosine-rich sequences found upstream of the promoter region of the SMARCA4 gene
Data (including data from studies using knockout mice) suggest that Brg1 is phosphorylated by casein kinase 2 (Ck2 (show CSNK2A1 ELISA Kits); Ck2alpha1 and Ck2alpha-prime are catalytic subunits) in proliferating skeletal myoblasts; Brg1 is catalytic subunit of SWI (show SMARCA1 ELISA Kits)/SNF (show SNRPA ELISA Kits) chromatin-remodeling enzymes; Ck2 (show CSNK2A1 ELISA Kits)-mediated phosphorylation of Brg1 appears to regulate myoblast proliferation. (Brg1 = Brahma (show SMARCA2 ELISA Kits)-related gene 1 protein)
BRG1 is a SOX10 (show SOX10 ELISA Kits) co-activator, required to establish the melanocyte lineage and promote expression of genes important for melanocyte function.
n keratinocytes, the promoter-enhancer anchoring regions in the gene-rich transcriptionally active TADs are enriched for the binding of chromatin architectural proteins CTCF (show CTCF ELISA Kits), Rad21 (show RAD21 ELISA Kits) and chromatin remodeler Brg1. In contrast to gene-rich TADs, gene-poor TADs show preferential spatial contacts with each other, do not contain active enhancers and show decreased binding of CTCF (show CTCF ELISA Kits), Rad21 (show RAD21 ELISA Kits) and Brg1 in keratinocytes
Data demonstrate that Brg1 plays an essential role in development and homeostasis, including morphogenesis, stem cell differentiation and cell survival in the duodenum.
Point mutations in SMARCA4 (also known as BRG1) mapping to the ATPase (show DNAH8 ELISA Kits) domain cause loss of direct binding between BAF (show BANF1 ELISA Kits) and PRC1 (show PRC1 ELISA Kits).
BRG1 promotes transcription of endothelial Mrtfa and Mrtfb, which elevates expression of SRF and SRF target genes that establish embryonic capillary integrity.
RB is necessary for the recruitment of the BRG1 ATPase (show DNAH8 ELISA Kits) to DNA double-strand breaks, which stimulates DNA end resection and homologous recombination
Cdx (show CDX1 ELISA Kits) members interact with the SWI (show SMARCA1 ELISA Kits)-SNF (show SNRPA ELISA Kits) complex and make direct contact with Brg1, a catalytic member of SWI (show SMARCA1 ELISA Kits)-SNF (show SNRPA ELISA Kits). Both Cdx2 (show CDX2 ELISA Kits) and Brg1 co-occupy a number of Cdx (show CDX1 ELISA Kits) target genes, and both factors are necessary for transcriptional regulation of such targets. Finally, Cdx2 (show CDX2 ELISA Kits) and Brg1 occupancy occurs coincident with chromatin remodeling at some of these loci.
BRG1/BRM (show SMARCA2 ELISA Kits) and c-MYC (show MYC ELISA Kits) have an antagonistic relationship regulating the expression of cardiac conduction genes that maintain contractility, which is reminiscent of their antagonistic roles as a tumor suppressor and oncogene (show RAB1A ELISA Kits) in cancer.
Results provide insights into the mechanisms by which Brg1 functions, which is in part via the p53 (show TP53 ELISA Kits) program, to constrain gene expression and facilitate rapid embryonic growth.
The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene.
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin a4
, transcription activator BRG1-like
, ATP-dependent helicase SMARCA4
, BRG1-associated factor 190A
, BRM/SWI2-related gene 1
, SNF2-like 4
, brahma protein-like 1
, global transcription activator homologous sequence
, homeotic gene regulator
, mitotic growth and transcription activator
, nuclear protein GRB1
, protein BRG-1
, protein brahma homolog 1
, sucrose nonfermenting-like 4
, transcription activator BRG1
, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4
, SWI/SNF related transcriptional activator
, WI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4